Delivery Order SPE2DB20D1047-SPE2DB25FF82J
Award Date 9/9/25
Potential Completion Date 9/10/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,763.00 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/mL vials, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,139.94 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/mL vials, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, will deliver the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,833.83 on September 2, 2025, for Pegasys 180 mcg/mL vials to support the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 3, 2025, with performance taking place at the contractor's Conshohocken facility. The award carries no set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PEGASYS 180 MCG/ML VIALML pharmaceuticals. The contract has a potential value of $8,220.18 and a completion date of January 26, 2024. This delivery order contract is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,072.25, is a Firm Fixed Price Delivery Order for the supply of PEGASYS 180 MCG/ML VIALML medical products. The contract has an ultimate completion date of April 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $6,706.70, this order is for the supply of 180 mcg/ml vials of PEGASYS to support DLA medical treatment programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required by December 8, 2023. No set-aside designation was applied to this award issued by...
- Amerisourcebergen Drug Corp has received a $6,036.03 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply PEGASYS 180 MCG/ML VIALML pharmaceutical products. As the prime contractor, Amerisourcebergen will deliver the specified medications to DLA from its headquarters in Conshohocken, Pennsylvania by November 17, 2023. No set-aside designation was applied to this award to support DLA's provision of pharmaceuticals and medical supplies for...
- This federal contract award, valued at $4,055.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The contract covers the delivery of PEGASYS 180 MCG/ML VIALML, a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,168.26 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $4,594.53. This firm fixed-price, competitively awarded delivery order is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency, and has an ultimate completion date of August 13, 2025. The award was made under no set-aside designation,...